The findings of a study indicate that the I/D polymorphism in the VEGF gene promoter is not linked to DN in West Indian patients with type 2 diabetes, but it may contribute to the development of non-diabetic nephropathy [42]. This evidence concerns the gene VEGFA and liver dysplastic nodule.